Brief: Adagene Inc - Cash And Cash Equivalents Were US$208.3 Mln As Of June 30, 2021, Compared To US$75.2 Mln As Of Dec. 31, 2020
Aug 26 (Reuters) - Adagene Inc 978y.F :
* ADAGENE REPORTS FINANCIAL RESULTS FOR THE SIX MONTHS ENDED
JUNE
30, 2021 AND PROVIDES CORPORATE UPDATES
* ADAGENE INC - CASH AND CASH EQUIVALENTS WERE US$208.3
MILLION AS
OF JUNE 30, 2021, COMPARED TO US$75.2 MILLION AS OF DECEMBER 31,
2020
Source text for Eikon: ID:nGNXb61HZg
Further company coverage: 978y.F
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Adagene
See all newsBrief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate
Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi